Serb Galenika Says It Secures Certificate for Drug Sales in EU
Galenika AD, Serbia’s state-owned drugmaker, said it received a compliance certificate for non-sterile products that allows their sales in the European Union.
Painkillers, anti-coagulants, anti-anxiety and diabetes drugs, exported so far to non-EU neighbors and Russia, will also be offered in Asia and Africa, following the approval by regulator in EU member Slovenia, the company said in an e-mailed statement.
To contact the reporter on this story: Misha Savic in Belgrade at firstname.lastname@example.org
To contact the editor responsible for this story: James M. Gomez at email@example.com